Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.98B |
| 2 |
Meta Platforms (Facebook)
META
|
+$997M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$860M |
| 4 |
Workday
WDAY
|
+$691M |
| 5 |
Amazon
AMZN
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$498M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$420M |
| 3 |
FedEx
FDX
|
+$350M |
| 4 |
Vale
VALE
|
+$340M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$322M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.96% |
| 2 | Technology | 2.07% |
| 3 | Consumer Discretionary | 1.49% |
| 4 | Financials | 1.12% |
| 5 | Communication Services | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHRN
12001
CALL
ChronoScale Holdings
CHRN
$2.73B
| $75K | ﹤0.01% |
1,727
+274
| +19% | +$10.7K |
|
12002
LiqTech
LIQT
$18.8M
| $75K | ﹤0.01% |
3,827
-865
| -18% | -$37.5K |
|
12003
NRX Pharmaceuticals
NRXP
$154M
| $75K | ﹤0.01% |
3,061
-4,835
| -61% | -$157K |
|
12004
PUT
SCYNEXIS
SCYX
$53.6M
| $75K | ﹤0.01% |
2,400
-13
| -0.5% | -$497 |
|
|
IMBI
12005
CALL
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $75K | ﹤0.01% |
+12,500
| New | +$77.5K |
|
12006
Abits Group
ABTS
$4.4M
| $74K | ﹤0.01% |
3,093
-930
| -23% | -$27.4K |
|
12007
CALL
Genie Energy
GNE
$391M
| $74K | ﹤0.01% |
+10,900
| New | +$64.3K |
|
12008
Turkcell
TKC
$4.7B
| $74K | ﹤0.01% |
19,017
-300,864
| -94% | -$1.07M |
|
|
MARK
12009
CALL
DELISTED
Remark Holdings, Inc.
MARK
| $74K | ﹤0.01% |
8,970
-7,430
| -45% | -$62.1K |
|
|
OIIM
12010
DELISTED
02Micro International
OIIM
| $74K | ﹤0.01% |
+17,800
| New | +$71.8K |
|
|
ADVM
12011
PUT
DELISTED
Adverum Biotechnologies
ADVM
| $73K | ﹤0.01% |
5,580
-1,120
| -17% | -$16.4K |
|
12012
PUT
Banco Bilbao Vizcaya Argentaria
BBVA
$160B
| $73K | ﹤0.01% |
12,900
-100
| -0.8% | -$612 |
|
|
DOYU
12013
CALL
DouYu International Holdings
DOYU
$129M
| $73K | ﹤0.01% |
3,510
-2,700
| -43% | -$59.5K |
|
12014
DSS Inc
DSS
$5.46M
| $73K | ﹤0.01% |
+6,820
| New | +$65.4K |
|
12015
CALL
ImmunityBio
IBRX
$8.53B
| $73K | ﹤0.01% |
13,000
-39,900
| -75% | -$245K |
|
12016
CALL
IGC Pharma
IGC
$32M
| $73K | ﹤0.01% |
76,700
+55,300
| +258% | +$53.7K |
|
12017
MaxCyte
MXCT
$126M
| $73K | ﹤0.01% |
10,498
-3,722
| -26% | -$25.4K |
|
12018
NetSol Technologies
NTWK
$49M
| $73K | ﹤0.01% |
+18,885
| New | +$75.6K |
|
12019
Red Cat Holdings
RCAT
$1.3B
| $73K | ﹤0.01% |
36,035
-48,341
| -57% | -$93K |
|
12020
CALL
cbdMD
YCBD
$5.6M
| $73K | ﹤0.01% |
194
-175
| -47% | -$59.1K |
|
|
IRD
12021
PUT
Opus Genetics
IRD
$307M
| $73K | ﹤0.01% |
22,600
+11,200
| +98% | +$38.3K |
|
|
CVT
12022
PUT
DELISTED
Cvent Holding Corp. Common Stock
CVT
| $73K | ﹤0.01% |
10,100
-52,200
| -84% | -$368K |
|
|
RMO
12023
CALL
DELISTED
Romeo Power, Inc.
RMO
| $73K | ﹤0.01% |
49,000
-543,800
| -92% | -$1.14M |
|
12024
CALL
Innoviz Technologies
INVZ
$104M
| $72K | ﹤0.01% |
19,800
+7,600
| +62% | +$30.4K |
|
12025
Kaltura
KLTR
$244M
| $72K | ﹤0.01% |
+40,139
| New | +$110K |
|
Similar funds
Jeff Yass's Q1 2022 Portfolio in Review
As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
- Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
- Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
- Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
- Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
- Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.
Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.